Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells
Abstract Background BRK is, a non-receptor tyrosine kinase, overexpressed in approximately 85% of human invasive ductal breast tumors. It is not clear whether BRK expression correlates with breast cancer subtypes, or the expression has prognostic or diagnostic significance. Herein, we investigated t...
Main Authors: | Sayem Miah, Edward Bagu, Raghuveera Goel, Yetunde Ogunbolude, Chenlu Dai, Alison Ward, Frederick S. Vizeacoumar, Gerald Davies, Franco J. Vizeacoumar, Deborah Anderson, Kiven Erique Lukong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-5186-8 |
Similar Items
-
Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
by: Raghuveera Kumar Goel, et al.
Published: (2018-08-01) -
Seeking a better understanding of the non-receptor tyrosine kinase, SRMS
by: Raghuveera Kumar Goel, et al.
Published: (2023-06-01) -
Estrogen Receptor Expression in Tumors Different from Breast Cancer
by: T. A. Bogush, et al.
Published: (2020-05-01) -
Citrus polymethoxyflavones degrade estrogen receptor-alpha (ERα) and combine with tamoxifen for the treatment of estrogen receptor-positive breast cancer
by: Yiyu Wang, et al.
Published: (2024-06-01) -
Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer
by: Faten Shehadeh-Tout, et al.
Published: (2023-07-01)